Expert NetworkExpert InterviewAVXL

Slingshot members are talking to an expert! The topic is:

Looking at the results from Anavex Life Sciences' Phase IIb/III Trial of Blarcamesine in Alzheimer's Disease

Executed on:Aug 6, 2024 10:30 AM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: University of Kansas
  • Director of NIH-funded University of Kansas Alzheimer's Disease Center.
  • Currently manages 300 patients with Alzheimer's disease.
  • Research is focused on brain energy metabolism, the role brain energy metabolism plays in Alzheimer's Disease, and how to manipulate brain energy metabolism.

Interview Goal

Discussing the standard of care and the results from Anavex Life Sciences Phase IIb/III Trial of Blarcamesine Presented at Alzheimer's Association Conference.

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.